Testosterone Monitoring Frequency During Treatment Changes
Initial Monitoring Phase
- The American College of Physicians recommends measuring testosterone at 2-3 months after treatment initiation or any dose change to assess treatment efficacy and determine if dose adjustments are needed, with subsequent monitoring at 3-6 month intervals during the first year, then yearly thereafter 1, 3
- Measure testosterone at 2-3 months after starting testosterone replacement therapy (TRT) or making dose adjustments to assess treatment efficacy and determine if dose adjustments are needed 1, 3
Maintenance Monitoring
- Monitor testosterone levels every 6-12 months while on therapy to ensure maintenance of therapeutic levels and early detection of supraphysiologic levels that could increase adverse event risk 1, 2
Critical Timing Considerations for Blood Draws
- Measure midway between injections (typically day 5-7 for weekly injections) targeting mid-normal values when using injectable testosterone formulations 1, 3
- Peak levels occur 2-5 days post-injection, with return to baseline by 10-14 days when using injectable testosterone formulations 3
Target Levels and Dose Adjustment Criteria
- The goal is to achieve total testosterone in the middle tertile of normal range (450-600 ng/dL) 2
- Discontinue therapy if target levels are achieved without symptom improvement after 3-6 months 2
Additional Monitoring Parameters
- Check PSA at each visit to detect prostate-related issues 3
- Monitor hematocrit/hemoglobin for erythrocytosis 3
- Evaluate symptomatic response, voiding symptoms, sleep apnea, and perform digital rectal examination at each follow-up visit 3
PSA-Specific Monitoring Thresholds
- Perform prostate biopsy or urology referral if PSA rises above 4.0 ng/mL 3
- Consider biopsy if PSA increases by ≥1.0 ng/mL within any 12-month period 3, 4